McBroom & Associates’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.37M Buy
36,886
+3,618
+11% +$843K 4.71% 8
2026
Q1
$8.13M Sell
33,268
-3,077
-8% -$717K 4.53% 9
2025
Q4
$7.52M Buy
36,345
+8,205
+29% +$1.62M 3.66% 14
2025
Q3
$5.22M Sell
28,140
-1,195
-4% -$205K 2.48% 19
2025
Q2
$4.86M Hold
29,335
2.78% 19
2025
Q1
$4.86M Sell
29,335
-730
-2% -$114K 2.78% 19
2024
Q4
$4.35M Sell
30,065
-1,369
-4% -$212K 2.46% 19
2024
Q3
$5.09M Buy
31,434
+3,345
+12% +$533K 3.12% 16
2024
Q2
$4.11M Buy
28,089
+215
+0.8% +$32K 2.57% 20
2024
Q1
$4.41M Sell
27,874
-339
-1% -$54K 2.9% 18
2023
Q4
$4.42M Sell
28,213
-798
-3% -$122K 3.22% 19
2023
Q3
$4.52M Buy
29,011
+2,113
+8% +$349K 3.6% 17
2023
Q2
$4.45M Buy
26,898
+767
+3% +$124K 3.51% 16
2023
Q1
$4.05M Sell
26,131
-1,717
-6% -$277K 3.62% 18
2022
Q4
$4.92M Sell
27,848
-1,263
-4% -$218K 5.34% 4
2022
Q3
$4.76M Sell
29,111
-411
-1% -$69.5K 5.36% 5
2022
Q2
$5.24M Sell
29,522
-334
-1% -$59.5K 5.7% 3
2022
Q1
$5.29M Sell
29,856
-441
-1% -$75K 4.69% 9
2021
Q4
$5.18M Buy
+30,297
New +$4.96M 3.9% 15

Other funds holding JNJ

McBroom & Associates's JNJ Position: Q2 2026 in Review

McBroom & Associates increased its Johnson & Johnson (JNJ) stake by 11% in Q2 2026, buying an estimated $843K and bringing the position to 36,886 shares worth $9.37M. The position accounts for 4.71% of the portfolio, ranked #8.

McBroom & Associates first reported a position in JNJ in Q4 2021 and has held it in 19 quarters since. 2,379 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • McBroom & Associates held 36,886 shares of Johnson & Johnson worth $9.37M as of Q2 2026.
  • McBroom & Associates bought 3,618 Johnson & Johnson shares in Q2 2026, an estimated $843K.
  • Johnson & Johnson made up 4.71% of McBroom & Associates's portfolio in Q2 2026, its #8 holding.
  • McBroom & Associates first reported a position in Johnson & Johnson in Q4 2021 and has held it in 19 quarters since.
  • 2,379 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on McBroom & Associates's 13F filing for Q2 2026, filed 30 Jul 2026.